Inside the Lab: Prof. Giordani’s Breakthrough Cancer Research

Prof. Silvia Giordani is pioneering the development of smart nanomaterials designed to transform how cancer drugs are delivered.


Video Feature:

Cancer treatments can be powerful. But they can also affect healthy cells, leading to difficult side effects for people with cancer.

That’s where this research comes in.

Prof. Silvia Giordani, Full Professor and Chair of Nanomaterials at Dublin City University, is pioneering the development of smart nanomaterials designed to transform how cancer drugs are delivered.

🧬 The focus? Tiny engineered structures called nanomaterials.

These incredibly small particles can act like precision delivery vehicles, carrying cancer therapies directly to tumour cells while helping to protect healthy tissue from unnecessary side effects.

🔬 Prof. Giordani’s research combines chemistry and nanotechnology to:

• Design smart nanomaterials that can carry cancer drugs through the body

• Deliver treatments directly to tumour cells with greater precision

• Reduce harmful side effects by limiting exposure to healthy tissue

• Support the development of more targeted and personalised cancer therapies

The goal is clear. More precise treatments, fewer side effects, and better outcomes for people with cancer.

Breakthrough Ireland supports researchers like Prof. Silvia Giordani as they work to develop new, better, smarter, kinder, and more effective cancer treatments. 💙

Silvia Giordani
Silvia Giordani
Full Professor Chair of Nanomaterials

My research interests are in the design, synthesis, and characterization of hybrid smart nanomaterials for biomedical, energy and environmental applications